Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
DNA Link, Inc., established in 2000 and listed on KOSDAQ (127120), is a pioneering genomics company based in South Korea. They specialize in providing comprehensive genomic analysis services, including Next-Generation Sequencing (NGS), microarray analysis, and bioinformatics. DNA Link focuses on areas such as Non-Invasive Prenatal Testing (NIPT), cancer genomics (e.g., liquid biopsy through their CancerSCAN service), personalized medicine, and pharmacogenomics. They aim to contribute to human health and disease understanding by translating genomic discoveries into practical applications for diagnostics, treatment, and direct-to-consumer (DTC) genetic testing.
Serves as the central hub for corporate management, administrative operations, and the core Research & Development activities focusing on genomic services, diagnostic product development, and bioinformatics.
Houses state-of-the-art genomics laboratories equipped for Next-Generation Sequencing (NGS), microarray analysis, and other advanced molecular biology techniques. Strategically located in an area with access to other biotech entities and research infrastructure.
DNA Link fosters a research-intensive and innovative work environment. The culture emphasizes scientific rigor, collaboration, and the practical application of genomic discoveries to improve healthcare outcomes.
The headquarters is pivotal for DNA Link's strategic direction, technological innovation, and operational execution, anchoring its position in the South Korean and global genomics market.
DNA Link operates globally with its main R&D and corporate functions based in Seoul, South Korea, and a significant operational presence in the United States through DNA Link USA, Inc. They provide genomic sequencing, bioinformatics analysis, NIPT, and cancer diagnostic services to a diverse international clientele, including research institutions, hospitals, and pharmaceutical companies worldwide. Their expansion efforts include partnerships in various regions, such as Southeast Asia.
9th FL, Park Media Center, 70, Garak-ro, Songpa-gu
Seoul
Seoul Special City
South Korea
Address: 11136 Greenstone Ave, Santa Fe Springs, CA 90670, USA
To expand DNA Link's market reach and service accessibility in North America, facilitating collaborations and providing localized support for its advanced genomic analysis services.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, DNA Link' leadership includes:
DNA Link has been backed by several prominent investors over the years, including:
Information on specific high-profile executive movements at DNA Link in the past 12 months is not readily available in public English-language sources. Key leadership appears stable. Official changes for publicly traded companies like DNA Link are typically disclosed through KOSDAQ filings.
Discover the tools DNA Link uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
DNA Link's email format can vary. A confirmed alias format is used for some key executives (e.g., jel@dnalink.com for the CEO). Another observed pattern for staff, particularly in international communications, is [firstname].[lastname]@dnalink.com. The primary domain is dnalink.com.
[alias]@dnalink.com and [firstname].[lastname]@dnalink.com
Format
jel@dnalink.com
Example
75%
Success rate
The Korea Economic Daily Global Edition • November 7, 2023
South Korean biotech firms DNA Link Inc. and Macrogen Inc. have partnered to launch a non-invasive prenatal test (NIPT) service, 'faest NIPT,' in Korea. This collaboration aims to enhance the accuracy and accessibility of prenatal screening for chromosomal abnormalities....more
Yakup (Korean Pharmaceutical Industry News) • June 22, 2023
DNA Link announced a contract to supply its liquid biopsy cancer diagnostic service, CancerSCAN, to Siriraj Hospital, Thailand's largest national hospital. This agreement signifies an important expansion of DNA Link's cancer diagnostic services into the Southeast Asian market....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including DNA Link, are just a search away.